David Ross Parkinson's Net Worth
$663 Thousand
Who is David Ross Parkinson?
David Ross Parkinson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FACET BIOTECH CORP, CTI BIOPHARMA CORP, ESSA Pharma Inc., Tocagen Inc, Cerulean Pharma Inc., THRESHOLD PHARMACEUTICALS INC, and AMBIT BIOSCIENCES CORP.
SEC CIK
David Ross Parkinson's CIK is 0001451935
Past Insider Trading and Trends
2022 was David Ross Parkinson's most active year for acquiring shares with 5 total transactions. David Ross Parkinson's most active month to acquire stocks was the month of April. 2023 was David Ross Parkinson's most active year for disposing of shares, totalling 7 transactions. David Ross Parkinson's most active month to dispose stocks was the month of May. 2022 saw David Ross Parkinson paying a total of $73,497.08 for 331,821 shares, this is the most they've acquired in one year. In 2010 David Ross Parkinson cashed out on 32,500 shares for a total of $877,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FACET BIOTECH CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.50K |
$27.00 | -$67,500.00 |
0
|
Apr 21
| |||
Form 4
| -76.92% | -8.33K |
$27.00 | -$224,991.00 | 2.5K |
Apr 20
| |||
Form 4
| +30.00% | 2.5K |
—
|
—
| 10.83K |
May 26
| |||
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CTI BIOPHARMA CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ESSA Pharma Inc. (EPIX) Snapshot price: $5.9
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +16.34% | 9.22K |
$2.30 | $21,212.90 | 65.67K |
Dec 14
| |||
Form 4
| +76.10% | 24.43K |
$2.42 | $59,041.33 | 56.54K |
Dec 22 - Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
| +17.95% | 4.89K |
$2.96 | $14,455.75 | 32.11K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Tocagen Inc (FBRX) Snapshot price: $7.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cerulean Pharma Inc. (DARE) Snapshot price: $3.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +132.48% | 16.23K |
$0.77 | $12,500.18 | 28.49K |
Jan 3
| |||
Form 4
|
∞
| 12.25K |
$1.02 | $12,499.08 | 12.25K |
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |